Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 9.255\% human ether-à-go-go related gene (hERG) inhibition at a concentration of 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a) CCCCOC(=O)c1ccc(NC(=O)C(=O)NCc2ccco2)cc1
b) O=C1/C(=C/c2ccc(Cl)cc2)NC(=S)N1Cc1cccnc1
c) O=C(/C=C/c1ccccc1Cl)Nc1ccc2c(c1)C(=O)NC2=O
d) COCCN1Cc2cccc(C(=O)Nc3cc(OC)ccc3OC)c2C1=O
e) COc1ccc(S(=O)(=O)Nc2cccc(N(C)S(C)(=O)=O)c2)cc1
Answer: b. O=C1/C(=C/c2ccc(Cl)cc2)NC(=S)N1Cc1cccnc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C1/C(=C/c2ccc(Cl)cc2)NC(=S)N1Cc1cccnc1
O=C1/C(=C/c2ccc(Cl)cc2)NC(=S)N1Cc1cccnc1
(5Z)-5-[(4-chlorophenyl)methylidene]-3-(pyridin-3-ylmethyl)-2-sulfanylideneimidazolidin-4-one